Ondansetron (Zofran) IV: Drug Safety Communication - QT prolongation
[Posted 06/29/2012] AUDIENCE : Oncology, Surgery, Gastroenterology ISSUE : The U.S. Food and Drug Administration (FDA) is informing healthcare professionals and the public that preliminary results from a recently completed clinical study suggest that a 32 …